Barclays’s IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN XXV Stock Holding History

Barclays’s Portfolio XXV Stock Details XXV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-22,214	Closed	-$844K	–	8040
2014 Q3	$844K	Hold	22,214	–	–	﹤0.01%	3508
2014 Q2	$844K	Hold	22,214	–	–	﹤0.01%	3491
2014 Q1	$844K	Sell	22,214 -9,857	-31%	-$379K	﹤0.01%	3420
2013 Q4	$1.22M	Hold	32,071	–	–	﹤0.01%	3170
2013 Q3	$1.22M	Buy	32,071 +23,214	+262%	+$891K	﹤0.01%	3132
2013 Q2	$338K	Buy	+8,857	New	+$339K	﹤0.01%	4674

Other funds holding XXV

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays's XXV Position: Q4 2014 in Review

Barclays sold out of IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN (XXV) in Q4 2014, closing a stake of 22,214 shares — an estimated $844K sold.

Barclays first reported a position in XXV in Q2 2013 and held it in 6 quarters. The position peaked at $1.22M in Q4 2013. 3 funds tracked by Wall St. Rank hold XXV as of Q4 2014.

Barclays reported no remaining IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN position as of Q4 2014 after selling out during the quarter.
Barclays sold 22,214 IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN shares in Q4 2014, an estimated $844K.
Barclays first reported a position in IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN in Q2 2013 and held it in 6 quarters.
Barclays's IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN position peaked at $1.22M in Q4 2013.
3 funds tracked by Wall St. Rank held IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN as of Q4 2014.

Based on Barclays's 13F filing for Q4 2014, filed 13 Feb 2015.